Latest round: Series B. Mike Carruthers serves as the Chief Financial Officer (CFO) of Edgewise Therapeutics.
Mike Carruthers serves as the Chief Financial Officer (CFO) of Edgewise Therapeutics, a biopharmaceutical company focused on muscular dystrophy treatments. He has been active in equity transactions, including selling company stock and receiving RSUs and stock options.
Full founder directory · Investor directory · Company funding database · Fundraising library
The Startup Fundraising Platform
Raise funds for your startup
Find the right investors and get real replies — instantly, powered by AI.
Takes 30 seconds · No credit card · Cancel anytime
Slide-by-slide guide